Healthpeak Properties (DOC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Voting matters and shareholder proposals
Shareholders will vote on the election of nine director nominees for the board for the upcoming term.
Advisory approval of 2025 executive compensation is on the agenda.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026, will be considered.
Proxies may vote on other business that arises during the meeting or any adjournments.
Board of directors and corporate governance
Nine individuals have been nominated for election to the board, including Scott M. Brinker, Katherine M. Sandstrom, and others.
Executive compensation and say-on-pay
Shareholders are asked to provide advisory approval of executive compensation for 2025.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Healthpeak Properties
- 2025 saw strong results, board refreshment, and enhanced ESG, with key votes on directors, pay, and auditor.DOC
Proxy Filing12 Mar 2026 - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - Janus Living IPO, $600M biotech campus acquisition, and $1B capital recycling drive growth.DOC
Investor presentation3 Mar 2026 - 2026 guidance anticipates a bottom in FFO, with growth expected as lab and senior housing recover.DOC
Q4 20253 Feb 2026 - Q2 net income surged, guidance raised, and $1.2B in asset sales completed.DOC
Q2 20242 Feb 2026 - Merger-driven scale, strong leasing, and robust financials support optimistic growth outlook.DOC
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong leasing, NOI growth, and higher guidance, fueled by merger synergies.DOC
Q3 202418 Jan 2026 - 2024 delivered strong growth and synergies, with 2025 set for continued investment and expansion.DOC
Q4 20248 Jan 2026 - Outpatient and life science platforms drive growth, with lab supply peaking and CCRC margins rising.DOC
Citi’s 30th Annual Global Property CEO Conference 20257 Jan 2026